XML 60 R43.htm IDEA: XBRL DOCUMENT v3.25.3

Business Segments and Geographic Information (Tables)

12 Months Ended

Sep. 27, 2025

Segment Reporting [Abstract]

Segment Information

Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company has presented all other identifiable assets as corporate assets.

									Year Ended September 27, 2025
									Diagnostics						Breast Health						GYN Surgical						Skeletal Health						Consolidated
Total revenues									$	1,827.2					$	1,484.1					$	679.8					$	109.4					$	4,100.5
Segment expenses:
Cost of revenues									689.6						611.2						208.3						90.3						1,599.4
Research and development									126.7						84.5						31.9						2.7						245.8
Sales and marketing									228.8						198.5						167.1						9.4						603.8
General and administrative									182.2						153.1						67.9						10.7						413.9
Segment income (loss) from operations									$	599.9					$	436.8					$	204.6					$	(3.7)					$	1,237.6
Unallocated amounts:
Cost of revenue adjustments(1)																																	23.3
Amortization of acquired intangible assets																																	190.9
Impairment of intangible assets and equipment																																	225.9
Restructuring, integration and acquisition-related charges																																	76.0
Other operating expense adjustments																																	7.2
Income from operations																																	$	714.3
Interest expense, net																																	(42.7)
Foreign currency and other non-operating income, net																																	9.6
Income before income taxes																																	$	681.2
(1) Primarily related to the fair value write-up of inventory sold related to the Gynesonics acquisition and costs associated with the shutdown of the Manchester, England manufacturing location, primarily accelerated depreciation and excess inventory charges.
			Year Ended September 27, 2025
			Diagnostics						Breast Health						GYN Surgical						Skeletal Health						Corporate						Consolidated
Depreciation and amortization			$	199.4					$	51.3					$	48.2					$	0.9					$	—					$	299.8
Capital expenditures			86.7						19.9						25.1						0.4						4.9						137.0
Identifiable assets			2,244.0						1,531.3						1,644.9						31.2						3,563.5						9,014.9

									Year Ended September 28, 2024
									Diagnostics						Breast Health						GYN Surgical						Skeletal Health						Consolidated
Total revenues									$	1,782.0					$	1,522.9					$	641.3					$	84.1					$	4,030.3
Segment expenses:
Cost of revenues									700.2						631.1						179.5						60.6						1,571.4
Research and development									151.0						79.4						28.9						3.4						262.7
Sales and marketing									239.1						191.7						144.7						9.8						585.3
General and administrative									182.2						144.0						63.7						10.8						400.7
Segment income (loss) from operations									$	509.5					$	476.7					$	224.5					$	(0.5)					$	1,210.2
Unallocated amounts:
Cost of revenue adjustments(2)																																	11.4
Amortization of acquired intangible assets																																	209.7
Impairment of intangible assets and equipment																																	44.8
Restructuring, integration and acquisition-related charges																																	51.7
Other operating expense adjustments																																	10.0
Income from operations																																	$	882.6
Interest expense, net																																	(13.4)
Foreign currency and other non-operating expenses, net																																	(4.1)
Income before income taxes																																	$	865.1
(2) Primarily related to the fair value write-up of inventory sold related to the Endomagnetics acquisition and charges for non-cancelable purchase orders related to a product line discontinuance in the Diagnostics division.
			Year Ended September 28, 2024
			Diagnostics						Breast Health						GYN Surgical						Skeletal Health						Corporate						Consolidated
Depreciation and amortization			$	218.8					$	41.6					$	48.1					$	0.5					$	—					$	309.0
Capital expenditures			80.2						30.9						16.6						1.4						1.1						130.2
Identifiable assets			2,431.3						1,588.9						1,419.9						48.3						3,667.6						9,156.0

									Year Ended September 30, 2023
									Diagnostics						Breast Health						GYN Surgical						Skeletal Health						Consolidated
Total revenues									$	1,880.1					$	1,432.7					$	604.2					$	113.4					$	4,030.4
Segment expenses:
Cost of revenues									699.1						609.0						164.2						76.8						1,549.1
Research and development									157.1						95.0						35.5						5.0						292.6
Sales and marketing									248.6						193.0						144.6						9.1						595.3
General and administrative									177.5						142.2						56.8						9.7						386.2
Segment income from operations									$	597.8					$	393.5					$	203.1					$	12.8					$	1,207.2
Unallocated amounts:
Cost of revenue adjustments(3)																																	24.6
Amortization of acquired intangible assets																																	233.8
Impairment of intangible assets and equipment																																	223.8
Loss on assets held-for-sale																																	51.7
Restructuring, integration and acquisition-related charges																																	14.1
Contingent consideration adjustments																																	(14.9)
Other operating expense adjustments																																	5.7
Income from operations																																	$	668.4
Interest income, net																																	9.4
Foreign currency and other non-operating expense, net																																	(1.7)
Income before income taxes																																	$	676.1
(3) Primarily related to the write off of inventory related to a product line discontinuance in the Diagnostics division.
			Year Ended September 30, 2023
			Diagnostics						Breast Health						GYN Surgical						Skeletal Health						Corporate						Consolidated
Depreciation and amortization			$	224.7					$	50.0					$	48.0					$	0.7					$	—					$	323.4
Capital expenditures			85.2						41.1						17.0						0.8						6.1						150.2
Segment assets			2,596.4						1,170.1						1,455.4						33.7						3,883.7						9,139.3

Revenues by Geography

Revenues by geography as a percentage of total revenues were as follows:

						Years Ended
						September 27, 2025						September 28, 2024						September 30, 2023
United States						74.3		%				75.0		%				75.9		%
Europe						14.5		%				13.2		%				12.9		%
Asia-Pacific						5.9		%				6.5		%				6.3		%
Rest of world						5.3		%				5.3		%				4.9		%
						100.0		%				100.0		%				100.0		%

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas

The Company’s property, plant and equipment were geographically located as follows:

						September 27, 2025						September 28, 2024						September 30, 2023
United States						$	412.5					$	379.7					$	367.6
Europe						74.1						70.6						67.0
Costa Rica						38.0						40.0						36.0
United Kingdom						16.6						32.0						32.4
Rest of world						18.4						15.5						14.0
						$	559.6					$	537.8					$	517.0

X

- Definition

Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration